Macrophage regulation of graft-vs-host disease

被引:0
|
作者
Ya-Qun Hong [1 ]
Bo Wan [2 ]
Xiao-Fan Li [1 ,3 ]
机构
[1] Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Department of Hematology, Fujian Medical University Union Hospital
[2] INSERM U1160, Hospital Saint Louis, Université Paris Diderot
[3] Faculty of Life Sciences and Medicine, King’s College London
关键词
Macrophage; Graft-vs-host disease; Hematopoietic stem cell transplantation; Polarization; Cytokine; Regulation;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Hematopoietic stem cell transplantation has become a curative choice of many hematopoietic malignancy, but graft-vs-host disease(GVHD) has limited the survival quality and overall survival of hematopoietic stem cell transplantation.Understanding of the immune cells’ reaction in pathophysiology of GVHD has improved, but a review on the role of macrophages in GVHD is still absent.Studies have observed that macrophage infiltration is associated with GVHD occurrence and development. In this review, we summarize and analyze the role of macrophages in GVHD based on pathophysiology of acute and chronic GVHD, focusing on the macrophage recruitment and infiltration, macrophage polarization, macrophage secretion, and especially interaction of macrophages with other immune cells. We could conclude that macrophage recruitment and infiltration contribute to both acute and chronic GVHD. Based on distinguishing pathology of acute and chronic GVHD, macrophages tend to show a higher M1/M2 ratio in acute GVHD and a lower M1/M2 ratio in chronic GVHD.However, the influence of dominant cytokines in GVHD is controversial and inconsistent with macrophage polarization. In addition, interaction of macrophages with alloreactive T cells plays an important role in acute GVHD.Meanwhile, the interaction among macrophages, B cells, fibroblasts, and CD4+ T cells participates in chronic GVHD development.
引用
收藏
页码:1793 / 1805
页数:13
相关论文
共 50 条
  • [1] Macrophage regulation of graft-vs-host disease
    Hong, Ya-Qun
    Wan, Bo
    Li, Xiao-Fan
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (10) : 1793 - 1805
  • [2] Graft-vs-host disease
    Woo, SB
    Lee, SJ
    Schubert, MM
    [J]. CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1997, 8 (02) : 201 - 216
  • [3] GRAFT-VS-HOST DISEASE
    SEURAT, J
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 1980, 19 (04) : 227 - 227
  • [4] Graft-vs-host disease
    S Pavletic
    [J]. Bone Marrow Transplantation, 2005, 36 (2) : 181 - 181
  • [5] PREVENTION OF GRAFT-VS-HOST DISEASE
    WOODS, WG
    [J]. AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1984, 6 (03): : 283 - 286
  • [6] Relief for Graft-vs-Host Disease
    Voelker, Rebecca
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (11): : 996 - 996
  • [7] Chronic graft-vs-host disease
    Bhushan, V
    Collins, RH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (19): : 2599 - 2603
  • [8] Eczematoid graft-vs-host disease
    Creamer, Daniel
    Martyn-Simmons, Claire L.
    Osborne, Genevieve
    Kenyon, Michelle
    Salisbury, Jon R.
    Devereux, Stephen
    Pagliuca, Antonio
    Ho, Aloysius Y.
    Mufti, Ghulam J.
    du Vivier, Anthony W. P.
    [J]. ARCHIVES OF DERMATOLOGY, 2007, 143 (09) : 1157 - 1162
  • [9] Mucosal graft-vs-host disease
    Lew, J.
    Smith, J. A.
    [J]. ORAL DISEASES, 2007, 13 (06) : 519 - 529
  • [10] Approaches to graft-vs-host disease
    Antin, JH
    [J]. PEDIATRIC TRANSPLANTATION, 2005, 9 : 71 - 75